Show simple item record

dc.creatorNishimi, Robyn Y.en
dc.date.accessioned2011-07-12T18:31:51Zen
dc.date.available2011-07-12T18:31:51Zen
dc.date.created1993-04-21en
dc.date.issued1993-04-21en
dc.identifier.bibliographicCitationJAMA: The Journal of the American Medical Association 1993 April 21; 269(15): 1921en
dc.identifier.urihttp://hdl.handle.net/10822/525346en
dc.formatArticleen
dc.languageengen
dc.source128686en
dc.subjectCystic Fibrosisen
dc.subjectDNAen
dc.subjectTechnologyen
dc.subjectTechnology Assessmenten
dc.subject.classificationGenetic Screening / Genetic Testingen
dc.titleFrom the Office of Technology Assessment: Cystic Fibrosis and DNA Tests--The Implications of Carrier Screeningen
dc.provenanceDigital citation created by the Bioethics Research Library, Georgetown University, for the National Information Resource on Ethics and Human Genetics, a project funded by the United States National Human Genome Research Instituteen
dc.provenanceDigital citation migrated from OpenText Livelink Discovery Server database named GenETHX to DSpace collection GenETHX hosted by Georgetown Universityen


This item appears in the following Collection(s)

Show simple item record


Georgetown University Seal
©2009—2019 Bioethics Research Library
Box 571212 Washington DC 20057-1212
202.687.3885